A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD

par Jara, Michele, Wentworth, Charles, Lanes, Stephan
Publié 2012

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

par Jara, Michele, Barker, Graham, Henney, Herbert R
Publié 2013

Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis

par Jara, Michele, Sidovar, Matthew F, Henney, Herbert R
Publié dans Ther Clin Risk Manag (2014)

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

par Jara, Michele, Aquilina, Thomas, Aupperle, Peter, Rabinowicz, Adrian L
Publié dans Drug Healthc Patient Saf (2015)